Back
CVE-2025-36228Incorrect Execution-Assigned Permissions in IBM Aspera Faspex
- 3.8LowCVSS base score
- 0.22%Exploitation in 30 daysEPSS · top 87% of all CVEs
- NoKnown exploitednot in CISA's KEV catalog
- NonePublic exploitsnone known yet
Description
IBM Aspera Faspex 5 5.0.0 through 5.0.14.1 may allow inconsistent permissions between the user interface and backend API allowed users to access features that appeared disabled, potentially leading to misuse.
Timeline
ID reserved
By ibm
- 9 months later
· 9 months later
Published
Changes after publication (a new score, a public exploit, EPSS crossing 1, 10 or 50 %, leaving KEV) are kept since November 2026; earlier ones are not known.
Scores
| Scored by | CVSS | Score | Vector |
|---|---|---|---|
| ibmCNA (assigner) | 3.1 | Low3.8 | CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:N |
| NVDNVD · Analyzed | 3.1 | Low3.8 | CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:N |
- EPSS (exploitation in 30 days)
- 0.22% · top 87% of all CVEs (13 Nov 2026)
- CISA SSVC
- Exploitation: none · Automatable: no · Technical impact: partial
Loading the EPSS history…
The list uses the assigner's score when there is one, then CISA's, then NVD's: Low 3.8.
Affected products
- affected 5.0.0 – ≤ 5.0.14.1
What to do
Solution: IBM strongly recommends addressing the vulnerabilities now by upgrading to Faspex 5.0.14 available from the link below.
References
References1
- https://www.ibm.com/support/pages/node/7255331 (opens in a new tab)vendor-advisorypatch
Sources
The same CVE in the primary databases and aggregators, to check against.
- CVE.org record (opens in a new tab)
- CVE List JSON (GitHub) (opens in a new tab)
- NVD (opens in a new tab)
- FIRST EPSS (opens in a new tab)
- EUVD EUVD-2025-205441 (opens in a new tab)
- OSV.dev (opens in a new tab)
- GitHub Advisories (opens in a new tab)
- CIRCL Vulnerability-Lookup (opens in a new tab)
Badge for a README or a ticket
[](https://cveledger.app/cve/CVE-2025-36228)Record last updated .